Zoetis (ZTS) Abbott Deal Seen as 'Good', BMO Capital Says; Focus Remains on Takeover Prospects (VRX)
Tweet Send to a Friend
BMO Capital analyst Alex Arfaei reiterated an Outperform rating and $49 price target on Zoetis Inc. (NYSE: ZTS) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
